Galileo Acquisition Corp. (GLEO) Shareholders Approve Shapeways Deal
by Marlena Haddad on 2021-09-29 at 6:35am

Galileo Acquisition Corp. (NYSE:GLEO) announced in an 8-K filing this morning that its shareholders approved its combination with additive manufacturing firm Shapeways, albeit with high redemptions.

In connection with the special meeting held yesterday, 11,018,352 shares were redeemed, removing 79.8% of Galileo’s trust. This comes as somewhat of a surprise as Galileo has traded steadily above $10 since late July but opened $0.05 below its estimated pro rata trust value of $10.09 on the day of its redemption deadline, September 24.

The $75 million PIPE involved in the deal appears to have been just enough for the SPAC to maintain its $100 million minimum cash condition in the transaction. The deal is now expected to be completed today. The combined company’s shares and warrants are expected to begin trading on the NYSE under the symbols “SHPW” and “SHPW WS”, on September 30.

Galileo originally announced its $410 million combination with Shapeways on April 28. Shapeways provides a software platform for designers to have digitally-designed parts or products optimized and manufactured out of its Long Island City, NY facilities.

The business combination and all other measures on the ballot were passed by wide margins at the special meeting. For full vote tallies and descriptions of proposals, click HERE.


ADVISORS

  • Stifel is serving as the exclusive financial and capital markets advisor to Shapeways and as sole placement agent to Galileo for the PIPE.
  • EarlyBirdCapital is serving as financial and capital markets advisor to Galileo.
  • Needham & Company and Craig-Hallum are acting as capital markets advisors to Galileo.
  • Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP is serving as legal advisor to Shapeways.
  • Ellenoff Grossman & Schole LLP is serving as legal advisor to Galileo.
  • ICR is serving as investor relations and communications advisor to Shapeways.
Recent Posts
by Nicholas Alan Clayton on 2024-04-18 at 11:50am

AGBA (NASDAQ:AGBA) stock is up over +90% this morning following a +211% premarket spike on news it has signed a definitive agreement to combine with social streaming video platform Triller. AGBA, the company itself, was formed by the $555 million combination between a SPAC of the same name and TAG Companies, a financial services firm...

by Nicholas Alan Clayton on 2024-04-18 at 7:57am

At the SPAC of Dawn Since closing its combination with DHC last month, AI customer engagement firm BEN (NASDAQ:BNAI) has rolled out new partnerships with call center and healthcare clients. And, while it faces a fair bit of competition in the chatbot realm, several high-profile institutions have demonstrated that creating one that provides useful services...

by Nicholas Alan Clayton on 2024-04-17 at 3:05pm

Blue Ocean (NASDAQ:BOCN) provided significantly more texture today in the presentation for its $275 million combination with Asian digital media group TNL Mediagene, which it expects to hit profitability in the second half of the year despite a slight shakeup in financing for the transaction. The first big update in the first investor deck is...

by Nicholas Alan Clayton on 2024-04-17 at 8:13am

At the SPAC of Dawn A brand new market may have just opened up for space de-SPACs as NASA administrator Bill Nelson announced a shift in the agency’s $11 billion program for a mission to return samples from Mars. Rather than rely on the agency’s internal technologies that would be predicted to get a sample...

by Nicholas Alan Clayton on 2024-04-16 at 11:33am

Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved